Command Palette

Search for a command to run...

Clinical Trials · NCT02879409

HbA1c Variability in Type II Diabetes

Active Not RecruitingN/ALiraglutide (Investigational)
Phase
N/A
Recruitment status
Active Not Recruiting
Sponsor
Weill Cornell Medical College in Qatar
Enrollment
150
Start date
Nov 2016
Locations
1 site, Qatar
Primary endpoint
Determination of the variability of HbA1c (by measurement of standard deviation of HbA1c) between the 2 diabetes treatment thresholds
View Liraglutide compound reference